Patrick K. Campbell, MD, PhD
Patrick K. Campbell, MD, PhD

Patrick K. Campbell, MD, PhD

Assistant Member, St. Jude Faculty

  • Associate Chief Medical Information Officer

Departments

Information Services Department
Oncology Department

Divisions

Clinical Informatics Division
Leukemia/Lymphoma Division

Education

BS – Haverford College, Haverford, Pennsylvania
PhD – Emory University Graduate School of Arts and Sciences, Atlanta, Georgia
MD – Emory University School of Medicine, Atlanta, Georgia

Honors & Awards

  • 2015  St. Jude Outstanding Physician Award
  • 2014  St. Jude Outstanding Clinical Care Improvement Award
  • 2011-2014  St. Jude Children’s Research Hospital Teaching Award

Research Interests

  • Langerhans cell histiocytosis and other histiocytic disorders
  • Chronic myeloid leukemia
  • Clinical education in pediatric hematology-oncology
  • Clinical informatics
  • Quality improvement and patient safety

Selected Publications

Nguyen R, Jeha S, Zhou Y, Cao X, Cheng C,Bhojwani D, Campbell P, Howard SC, Rubnitz J, Ribeiro RC, Sandlund JT, Gruber T, Inaba H, Pui CH, Metzger ML.The Role of Leukapheresis in the Current Management of Hyperleukocytosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia. Pediatr Blood Cancer May 17, 2016.

Diamond EL, Durham BH, Haroche J, Yao Z, Ma J, Parikh SA, Wang Z, Choi J, Kim E, Cohen-Aubart F, Lee SC, Gao Y, Micol JB, Campbell P, Walsh MP, Sylvester B, Dolgalev I, Aminova O, Heguy A, Zappile P, Nakitandwe J, Ganzel C, Dalton JD, Ellison DW, Estrada-Veras J, Lacouture M, Gahl WA, Stephens PJ, Miller VA, Ross JS, Ali SM, Briggs SR, Fasan O, Block J, Heritier S, Donadieu J, Solit DB, Hyman DM, Baselga J, Janku F, Taylor BS, Park CY, Amoura Z, Dogan A, Emile JF, Rosen N, Gruber TA, Abdel-Wahab O. Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Discov 6(2):154-165, 2016. PMCID:26566875

Kaste SC, Pei D, Cheng C, Neel MD, Bowman WP, Ribeiro RC, Metzger ML, Bhojwani D, Inaba H, Campbell P, Rubnitz JE, Jeha S, Sandlund JT, Downing JR, Relling MV, Pui CH, Howard SC. Utility of Early Screening Magnetic Resonance Imaging for Extensive Hip Osteonecrosis in Pediatric Patients Treated With Glucocorticoids. Journal of Clinical Oncology 33(6):610-5. PMCID:PMC4322260 

Fernandez CA, Stewart E, Panetta JC, Wilkinson MR, Morrison AR, Finkelman FD, Sandlund JT, Pui CH, Jeha S, Relling MV, Campbell PK. Successful challenges using native E. coli asparaginase after hypersensitivity reactions to PEGylated E. coli asparaginase. Cancer Chemotherapy Pharmacology 73(6):1307-1313, 2014. PMCID: PMC4137479

Rubnitz JE, Campbell P, Zhou Y, Sandlund JT, Jeha S, Ribeiro RC, Inaba H, Bhojwani D, Relling MV, Howard SC, Campana D, Pui CH. Prognostic impact of absolute lymphocyte counts at the end of remission induction in childhood acute lymphoblastic leukemia. Cancer  119(1):2061-2066, 2013. PMCID: PMC3862024

Abraham A, Alsultan A, Jeng M, Rodriguez-Galindo C, Campbell PK. Clofarabine salvage therapy for refractory high-risk Langerhans cell histiocytosis. Pediatr Blood Cancer 60(6):E19-E22, 2013. PMID: 23255383

Campbell PK, Zong Y, Yang S, Zhou S, Rubnitz JE, Sorrentino BP. Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia. Leuk Res June 1, 2011. PMCID: PMC3163718

Ikegami K, Heier RL, Taruishi M, Takagi H, Mukai M, Shimma S, Taira S, Hatanaka K, Morone N, Yao I, Campbell PK, Yuasa S, Janke C, MacGregor GR, Setou M. Loss of α-tubulin polyglutamylation in ROSA22 mice is associated with abnormal targeting of KIF1A and modulated synaptic function.PNAS  104: 3213-3218, 2007. PMCID: PMC1802010

Campbell PK, Waymire KG, Heier RL, Sharer C, Day DE, Reimann H, Jaje JM, Friedrich GA, Burmeister M, Bartness TJ, Russell LD, Young LJ, Zimmer M, Jenne DE, MacGregor GR. Mutation of a novel gene results in abnormal development of spermatid flagella, loss of intermale aggression and reduced body fat in mice. Genetics 162: 307-320, 2002. PMCID: PMC1462267

Last update: June 2016